Status:
COMPLETED
Utilizing Augmented Reality as an Adjunct for Smoking Cessation
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.
Eligibility Criteria
Inclusion
- Currently smoking ≥ 3 cigarettes per day for the past year
- Breath carbon monoxide (CO) level ≥ 5 ppm
- Motivated to quit smoking
- Aim 1 \& 2 Only: Valid home address in the Tampa Bay area
- Functioning telephone number
- Can speak, read, and write in English
- Aim 3: Must have a smartphone that participant is willing to use during the study
- Aim 3: Motivated to quit smoking within the next month
Exclusion
- Regular use (e.g., no more than 1/3 of month) of other tobacco products (cigars)
- Household member already enrolled in the study
Key Trial Info
Start Date :
October 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2022
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT04101422
Start Date
October 7 2019
End Date
February 14 2022
Last Update
May 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612